Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) declared a special dividend on Tuesday, November 17th. Stockholders of record on Monday, November 30th will be given a dividend of $2.00 per share on Monday, December 14th. The ex-dividend date is Monday, November 30th.
Nutex Health Stock Up 2.8%
NASDAQ:NUTX traded up $4.81 on Tuesday, hitting $174.51. 175,126 shares of the company’s stock were exchanged, compared to its average volume of 165,851. The firm has a 50-day moving average price of $201.83 and a 200-day moving average price of $152.17. The company has a debt-to-equity ratio of 0.59, a current ratio of 4.76 and a quick ratio of 4.96. Nutex Health has a 52 week low of $83.99 and a 52 week high of $226.16. The company has a market cap of $1.20 billion, a P/E ratio of 7.45 and a beta of 0.66.
Nutex Health (NASDAQ:NUTX – Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.54 by $0.17. Nutex Health had a net margin of 20.68% and a return on equity of 34.43%. The company had revenue of $217.61 million for the quarter, compared to analysts’ expectations of $214.82 million. As a group, analysts expect that Nutex Health will post 27.70 EPS for the current fiscal year.
Insider Activity at Nutex Health
In other news, Director Scott Saunders sold 203 shares of the company’s stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the sale, the director directly owned 400 shares of the company’s stock, valued at approximately $85,700. This represents a 33.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 44.68% of the stock is currently owned by corporate insiders.
Institutional Trading of Nutex Health
Large investors have recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Nutex Health during the 2nd quarter valued at about $69,612,000. Winmill & CO. Inc. bought a new stake in shares of Nutex Health in the second quarter worth approximately $11,168,000. Empowered Funds LLC bought a new stake in shares of Nutex Health in the second quarter worth approximately $7,720,000. Bank of New York Mellon Corp purchased a new position in shares of Nutex Health during the second quarter valued at approximately $3,956,000. Finally, Bridge City Capital LLC purchased a new position in shares of Nutex Health during the third quarter valued at approximately $3,918,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.
Nutex Health Company Profile
Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.
Recommended Stories
- Five stocks we like better than Nutex Health
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
